A cross sectional study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2014
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms X-Sectional
- 13 Jun 2012 Actual patient number is 327 according to ClinicalTrials.gov.
- 12 Oct 2009 New trial record.